Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 1 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| COVID-19 | 1 |
| Costs | 1 |
| Drug Therapy | 1 |
| Foreign Countries | 1 |
| Intellectual Property | 1 |
| Pandemics | 1 |
| Pharmaceutical Education | 1 |
| Pharmacy | 1 |
Author
| Cristina Vilaplana Prieto | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
| Higher Education | 1 |
| Postsecondary Education | 1 |
Audience
Location
| Bangladesh | 1 |
| Brazil | 1 |
| China | 1 |
| Egypt | 1 |
| France | 1 |
| India | 1 |
| Malaysia | 1 |
| Pakistan | 1 |
| South Africa | 1 |
| Sweden | 1 |
| Turkey | 1 |
| More ▼ | |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Download full textCristina Vilaplana Prieto – European Journal of Education (EJED), 2021
As the Sars-CoV2 pandemic continues to grow, researchers around the world are urgently seeking new treatments to prevent infection, cure those infected, or lessen the severity of the disease. Although there are several recently approved vaccines, clinical trials are underway to "re-use" drugs normally indicated for other diseases. This…
Descriptors: COVID-19, Pandemics, Pharmacy, Drug Therapy
